News
Abbott says that its EAS Sports Nutrition is helping serious athletes train harder through nine redesigned Myoplex products that deliver the nutrition athletes need before, during and after workouts.
Abbott says that its EAS Sports Nutrition is helping serious athletes train harder through nine redesigned Myoplex products that deliver the nutrition athletes need before, during and after workouts. The new line is said to help athletes improve power, sustain performance, build muscle and recover strong so they can achieve their personal best.
Abbott says that the new products use innovative ingredient combinations in clinically proven amounts that support athletes' energy, muscle and recovery needs. "This is our most scientifically advanced line yet," said Steve Hertzler, EAS scientific officer and architect of the Myoplex line. "We've introduced technology like our E3 Fusion blend which has three proven ingredients that work together to help decrease muscle breakdown and promote new growth. Also, our Pre-Workout nutrition helps increase workout capacity and performance. Every product is designed to nutritionally deliver what's needed to sustain Products from the new line include:+Myoplex Pre-Workout is a blend of beetroot extract, beta-alanine, caffeine, creatine monohydrate and Peak ATP nutrients. It's designed to be used before hitting the gym and can help athletes train harder by increasing workout capacity and stamina.+ Myoplex BCAA + Electrolytes is for use during a workout to sustain performance. It features a 2:1:1 ratio of branched chained amino acids to promote muscle protein synthesis and includes electrolytes to maintain hydration during intense workouts.+ Myoplex Protein Blend aids in post-workout recovery by combining quick- and-slow digesting proteins with E3 Fusion to provide muscle-building nutrition for up to seven hours. E3 Fusion is a blend of HMB, phosphatidylserine and leucine that helps to increase muscle protein synthesis and decrease muscle protein breakdown. + Myoplex Micellar Casein aids in repair and recovery and is designed to be taken at night. The slow-digesting casein protein provides sustained amino acids throughout the night and includes the E3 Fusion blend. To improve relaxation, the product has a Rest Matrix blend of nutrients.
23 Dec 2025
From trade tariffs to heavy metals in protein, we look back at some of the industry’s highlights of 2025 and round up our most-read stories of the year.
Read more
19 Dec 2025
Non-profit organisation the Food Foundation has launched a campaign, “Bang in Some Beans”, designed to increase UK consumers’ legume consumption.
Read more
12 Dec 2025
Europe’s $40.7 billion supplements market is growing fast, fuelled by demand for products that support healthy ageing, mental wellbeing, and preventive health, say experts.
Read more
11 Dec 2025
Whole Foods Market has released its top 2026 trends, predicting that a fibre frenzy will take place next year as health-conscious consumers seek out nutritious, filling options.
Read more
9 Dec 2025
With the launch of Novak Djokovic’s sorghum-based brand, the grain’s popularity in the better-for-you snacking sphere is on the rise, thanks to its nutritional and sensory properties.
Read more
8 Dec 2025
Plant-based dairy is a maturing market that still faces significant hurdles around taste, functionality, nutrition, and price, but industry is innovating fast, according to experts speaking at Fi Europe.
Read more
3 Dec 2025
Food industry stakeholders celebrated as the winners of the Fi Europe Innovation Awards were announced at a ceremony in Paris.
Read more
28 Nov 2025
Entries for the Vitafoods Europe Innovation Awards 2026 are now open! Game-changing companies have until 27 February to submit their entry across eight categories for the chance to win big.
Read more
25 Nov 2025
Cinnamon may be a top functional ingredient, but it needs stronger protocols to ensure it meets EU food safety laws and quality standards, say researchers.
Read more
24 Nov 2025
OXO’s entry into bone broth has turned the spotlight on this small but high-performance category – and there is still scope for growth, especially in the area of GLP-1 support.
Read more